Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
Hisatomi
K
K
Second Department of Surgery, Faculty of Medicine, Kagoshima University Hospital, Japan.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000473:pathology / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011183:Postoperative Complications; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D007166:Immunosuppressive Agents; D016572:Cyclosporine